# Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

> **NCT01269151** · NA · COMPLETED · sponsor: **University of Luebeck** · enrollment: 20 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Retinal Function

## Interventions

- **DRUG:** Lucentis (Ranibizumab)

## Key facts

- **NCT ID:** NCT01269151
- **Lead sponsor:** University of Luebeck
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-03
- **Final completion:** 2014-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01269151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01269151, "Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01269151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*